Inventor · disambiguated record
Melissa L. Fishel
Also filed as: FISHEL MELISSA · FISHEL MELISSA L
6 granted patents·3 pending applications·11 citations·filing 2013–2023
76Inventor score
Top patents by PatentIndex Score
9 records- 0194US11648226B2Use of APE1/Ref-1 inhibitors for treatment of retinal diseasesUNIV INDIANA RES & TECH CORP·Filed 2020·Granted May 16, 2023·4 cites·6 claims
- 0281US12350247B2Use of APE1/Ref-1 inhibitors for treatment of retinal diseasesUNIV INDIANA RES & TECH CORP·Filed 2023·Granted Jul 8, 2025·0 cites·7 claims
- 0377US9315481B2Compounds and methods for treating leukemiaUNIV INDIANA RES & TECH CORP·Filed 2013·Granted Apr 19, 2016·3 cites·5 claims
- 0475US10772859B2Methods of targeting APE/Ref-1 to inhibit hypoxia signaling genesUNIV INDIANA RES & TECH CORP·Filed 2016·Granted Sep 15, 2020·1 cites·3 claims
- 0574US9650399B2Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereofGOVERNING COUNCIL UNIV TORONTO·Filed 2013·Granted May 16, 2017·3 cites·16 claims
- 0662US2019160034A1Use of ape1/ref-1 inhibitors in combination therapies for treatment of cancerUNIV INDIANA RES & TECH CORP·Filed 2018·Application pending·0 cites
- 0753US2019382422A1Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereofGOVERNING COUNCIL UNIV TORONTO·Filed 2019·Application pending·0 cites
- 0847US10377780B2Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereofGOVERNING COUNCIL UNIV TORONTO·Filed 2017·Granted Aug 13, 2019·0 cites·15 claims
- 0946US2019365689A1Use of ape/ref-1 redox specific inhibitors for treating metastatic prostate cancerUNIV INDIANA RES & TECH CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Melissa L. Fishel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →